<PAGE>
===============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
----------------
Date of Report (Date of earliest Commission File Number 0-23252
event reported) December 30, 1999
IGEN INTERNATIONAL, INC.
(Exact name of registrant)
Delaware 94-2852543
(State of organization) (I.R.S. Employer Identification Number)
16020 Industrial Drive, Gaithersburg Maryland 20877
(Address of principal executive offices and zip code)
(301) 869-9800
(Registrant's telephone Number)
===============================================================================
<PAGE>
ITEM 5. OTHER EVENTS
On December 30, 1999, the U.S. Court of Appeals for the Fourth Circuit affirmed
a preliminary injunction that the U.S. District Court for the District of
Maryland had issued against Roche Diagnostics, GmbH, the diagnostics unit of F.
Hoffman La Roche. The preliminary injunction, issued in 1998, enjoined Roche
from marketing products based on IGEN International, Inc.'s ORIGEN(R) technology
to physician office laboratories. The preliminary injunction also required Roche
to transfer existing customers to IGEN and to escrow all revenues from physician
office laboratory sales pending the final outcome of the lawsuit that IGEN filed
against Roche in 1997. The lawsuit, as discussed in more detail in IGEN's Form
10-K for the fiscal year ended March 31, 1999 and Form 10-Q's for the quarters
ended June 30, 1999 and September 30, 1999, claims multiple breaches of a 1992
license agreement between IGEN and Roche concerning IGEN's ORIGEN technology.
The legal action includes charges that Roche has underreported its royalties and
has sold ORIGEN-based systems outside of its licensed field.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IGEN INTERNATIONAL, INC.
BY: /s/ George V. Migausky
-------------------------------
George V. Migausky
Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)
Dated: January 27, 2000
